Aarti Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Drugs Limited has submitted a certificate to the stock exchange as required under the SEBI (Depositories and Participants) Regulations, 2018. This is a routine compliance filing related to the company's dealings with depositories, typically covering share capital reconciliation, dematerialization, or related participant activities. The filing itself does not disclose any new financial figures, business developments, or strategic actions. Such certificates are submitted periodically as part of ongoing regulatory obligations for listed companies.
This is a standard regulatory compliance filing with no material impact on the company's operations, financials, or shareholder value. Retail investors should note that this does not signal any corporate action or change in business direction.